Carnosic Acid

Carnosic acid is a naturally occurring phenolic diterpene, more precisely an abietane-type benzenediol diterpene, found in high concentrations in two familiar culinary herbs: rosemary (Salvia rosmarinus, formerly Rosmarinus officinalis) and common sage (Salvia officinalis) ^[1]. It is one of the principal compounds responsible for the antioxidant properties of these plants, and their dried leaves can contain it at a level of a few percent by weight ^[1]. Chemically it is closely related to carnosol, another rosemary diterpene into which it is readily converted ^[4].

A defining feature of carnosic acid is its reactivity as an antioxidant. It carries an ortho-dihydroquinone group and behaves as a so-called pro-electrophile: it is relatively unreactive until it encounters oxidizing free radicals, whereupon it is converted into an electrophilic form ^[4]. This makes it prone to oxidation, and on exposure to air and light it degrades, in part forming carnosol, which is one reason rosemary extracts are prized for their stabilizing effect in fatty foods ^[4].

Because of this antioxidant activity, carnosic acid and carnosol are used commercially as natural preservatives. In food and some non-food products they are added, under the designation rosemary extract (E number E392), to slow the oxidation of fats and oils and extend shelf life ^[1]. This food-additive role, alongside the culinary use of the whole herbs, is the most established practical application of the compound.

Most biomedical research on carnosic acid has focused on its antioxidant, anti-inflammatory, and neuroprotective effects, with additional interest in possible anticancer activity ^[1]. Rather than acting only as a direct radical scavenger, carnosic acid works largely as an indirect antioxidant by activating the KEAP1/Nrf2 pathway, a master cellular switch that turns on a battery of protective and detoxifying enzymes ^[3][5]. Through this and related mechanisms it has been reported to dampen inflammatory signaling, including the NLRP3 inflammasome, to protect the mitochondria of brain cells, and to cross the blood-brain barrier, prompting study of its potential against neurodegenerative conditions such as Alzheimer's and Parkinson's disease ^[2][3][4]. These findings come largely from laboratory and animal experiments, and rigorous clinical trials in humans remain limited ^[1].

As a constituent of ordinary herbs and a permitted food antioxidant, carnosic acid is generally regarded as safe at the levels encountered in food, and it is also sold, usually as a standardized rosemary extract, as a dietary supplement ^[1]. Its promise as a therapeutic agent remains at the research stage rather than established medical practice ^[2].

Carnosic acid, and the rosemary extracts that supply it, has a long history of dietary use and is generally considered well tolerated at the low levels found in food and typical supplement doses. Acute animal toxicity is low, with an oral LD50 in mice of about 7.1 g/kg ^[6], and regulatory bodies such as the European Food Safety Authority have set a temporary acceptable daily intake for the combined carnosic acid and carnosol content of rosemary extract in the range of a few tenths of a milligram per kilogram of body weight per day.

Safety at higher supplemental doses is less well characterized; some studies raise the possibility of liver and kidney stress, and effects on reproductive and hormonal function with prolonged high intake, so very high doses are not advised. Concentrated rosemary preparations and essential oils should not be used in large amounts during pregnancy because of a theoretical risk of stimulating uterine activity. People with liver disease or those taking anticoagulant or antidiabetic medication should consult a clinician before regular use, since the compound may interact with these therapies.

Carnosic acid is a phenolic diterpene first isolated in the 1960s from sage species of the genus Salvia, from which it takes its name, and subsequently identified as one of the principal antioxidant constituents of rosemary (Rosmarinus officinalis, now often classified as Salvia rosmarinus). Its chemical structure was elucidated by natural product chemists over the following decade.

For most of the twentieth century it was studied chiefly as the compound responsible for the food-preservative and antioxidant properties of rosemary extract, which is widely used in the food industry to retard the oxidation of fats and oils. Interest in its neurobiology grew later, driven by observations that it activates the Nrf2 antioxidant response pathway and that it is converted to its active form under conditions of oxidative stress, a property that prompted investigation into its potential neuroprotective applications.

Carnosic acid is generally well regarded within the antioxidant and neuroprotection research communities, where it is valued for its unusual redox-activated mechanism and its ability to cross the blood-brain barrier. Among consumers it is encountered less as a stand-alone product and more as the standardized active fraction of rosemary extract marketed for cognitive, anti-inflammatory, and general antioxidant support. Enthusiasm is tempered by the recognition that much of the supporting evidence comes from cell and animal studies rather than large human trials, and that oral bioavailability is modest. It is often viewed as a promising but still preliminary botanical compound rather than an established therapeutic.